Japan Nod For Quizartinib In First-Line AML

First FLT3 Inhibitor For Use

 
• By Lisa Takagi
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia